title: Infusion reactions related to infliximab therapy are not usually associated with drug discontinuation.
authors.forename: Garrett
authors.initials: G
authors.lastname: Cullen
authors.forename: Adam S
authors.initials: AS
authors.lastname: Cheifetz
mesh_terms: D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D018501:Antirheumatic Agents / Q000009:adverse effects*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D005260:Female; D006801:Humans; D000069285:Infliximab; D008297:Male
chemical_list: D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D000069285:Infliximab